IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools
 

Search About Journals, Conferences, and Book Series


Drug Resistance Updates- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

22.22

h-Index

 119

Rank

 409

SJR

 3.845

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Drug Resistance Updates
Abbreviation Drug Resist. Updates
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)
h-index 119
Overall Rank/Ranking 409
SCImago Journal Rank (SJR) 3.845
Impact Score 22.22
Publisher Churchill Livingstone
Country United States
ISSN 13687646, 15322084




Aim and Scope


Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews and commentaries on important developments in drug resistance in infectious disease and cancer.

It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, oncology and clinical medicine.

Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication.


About Drug Resistance Updates


Drug Resistance Updates is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1). It is published by Churchill Livingstone. The overall rank of Drug Resistance Updates is 409. According to SCImago Journal Rank (SJR), this journal is ranked 3.845. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 119. The best quartile for this journal is Q1.

The ISSN of Drug Resistance Updates journal is 13687646, 15322084. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Resistance Updates is cited by a total of 1409 articles during the last 3 years (Preceding 2021).




Drug Resistance Updates Impact Score 2021-2022


The impact score (IS) 2021 of Drug Resistance Updates is 22.22, which is computed in 2022 as per its definition. Drug Resistance Updates IS is increased by a factor of 4.99 and approximate percentage change is 28.96% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Drug Resistance Updates Impact Score 2022 Prediction


IS 2021 of Drug Resistance Updates is 22.22. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Drug Resistance Updates. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 22.22
2020 17.23
2019 10.74
2018 12.06
2017 12.25
2016 12.10
2015 8.74
2014 10.03

Drug Resistance Updates h-index


  Table Setting

Drug Resistance Updates has an h-index of 119. It means 119 articles of this journal have more than 119 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Drug Resistance Updates ISSN


The ISSN of Drug Resistance Updates is 13687646, 15322084. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Drug Resistance Updates Rank and SCImago Journal Rank (SJR)


The overall rank of Drug Resistance Updates is 409. According to SCImago Journal Rank (SJR), this journal is ranked 3.845. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Drug Resistance Updates Publisher


Table Setting

Drug Resistance Updates is published by Churchill Livingstone. It's publishing house is located in United States. Coverage history of this journal is as following: 1998-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Drug Resistance Updates is Drug Resist. Updates. This abbreviation ('Drug Resist. Updates') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Drug Resistance Updates


If your research field is/are related to Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Africa journal 9986 Cambridge University Press 45 0.94
TechTrends journal 6434 Springer New York 42 2.30
Petroleum Economist trade journal 26765 Petroleum Economist Ltd. 4 0.01
Global Sustainability journal 1917 Cambridge University Press 16 5.40
Journal of Energy Engineering - ASCE journal 11482 American Society of Civil Engineers (ASCE) 33 2.08
Greek Review of Social Research journal 22095 National Centre for Social Research 2 0.31
Business Ethics Quarterly journal 2021 Cambridge University Press 81 3.34
Virologica Sinica journal 3187 Ko hsueh chu pan she 35 5.74
Applied Categorical Structures journal 7819 Springer Netherlands 29 0.96
Middle East Journal, The journal 15049 Middle East Institute 39 0.62

Check complete list



Jasper


Year wise Impact Score (IS) of Drug Resistance Updates

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 22.22
2020 17.23
2019 10.74
2018 12.06
2017 12.25
2016 12.10
2015 8.74
2014 10.03



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

See All

Top Journals/Conferences in Infectious Diseases

Immunity
Cell Press | United States

Nature Reviews Microbiology
Nature Publishing Group | United Kingdom

Clinical Microbiology Reviews
American Society for Microbiology | United States

Lancet Infectious Diseases, The
Lancet Publishing Group | United Kingdom

Microbiology and Molecular Biology Reviews
American Society for Microbiology | United States

FEMS Microbiology Reviews
Oxford University Press | United Kingdom

Lancet HIV,The
Elsevier Ltd. | United Kingdom

Trends in Microbiology
Elsevier Ltd. | United Kingdom

Current Opinion in Microbiology
Elsevier Ltd. | United Kingdom

Clinical Infectious Diseases
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All

Top Journals/Conferences in Pharmacology (medical)

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Neurotherapeutics
Springer New York | United States

ACS Pharmacology and Translational Science
American Chemical Society | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Journal of acquired immune deficiency syndromes (1999)
Lippincott Williams and Wilkins Ltd. | United States

Journal of Antimicrobial Chemotherapy
Oxford University Press | United Kingdom

See All